Literature DB >> 380842

Importance of blood-collection tubes in plasma lidocaine determinations.

W W Stargel, C R Roe, P A Routledge, D G Shand.   

Abstract

In 25 clinical samples serum lidocaine concentrations fell from a mean of 6.5 +/- 2.1 mg/L (mean +/- SD) to 4.9 +/- 1.8 mg/L (p less than 0.001) when the blood sample was allowed to make contact with the stopper of the Vacutainer collection tube. In vitro experiments showed that this effect of the stopper occurred only with whole blood and was dependent on sample concentration. The plasma binding of lidocaine decreased from a normal value of 56% +/- 2.2 (mean +/- SD) to 28% +/- 2.2 (p less than 0.001) when exposed to the Vacutainer stopper. We conclude that a chemical leached from such stoppers displaces lidocaine from its plasma-binding sites and that the drug is then redistributed into the erythrocytes, producing spuriously low lidocaine concentrations in plasma or serum. Such artifacts are important in therapeutic drug monitoring and can lead to erroneous clinical decisions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 380842

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  8 in total

1.  Fluphenazine, trifluoperazine and perphenazine in Vacutainers.

Authors:  K K Midha; J K Cooper; Y D Lapierre; J W Hubbard
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

2.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 3.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

4.  Potential applications of free drug level monitoring in cardiovascular therapy.

Authors:  R L Woosley; L A Siddoway; K Thompson; I Cerskus; D M Roden
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

5.  On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.

Authors:  A Barchowsky; D G Shand; W W Stargel; G S Wagner; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

6.  The influence of blood collection technique on serum and plasma protein binding of disopyramide.

Authors:  D B Haughey; J J Lima
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  alpha 1-Acid glycoprotein and plasma lidocaine binding.

Authors:  D G Shand
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

8.  Do evacuated blood collection tubes interfere with therapeutic drug monitoring?

Authors:  R Janknegt; J J Lohman; P M Hooymans; F W Merkus
Journal:  Pharm Weekbl Sci       Date:  1983-12-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.